Axa’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-41,319
| Closed | -$3.08M | – | 390 |
|
|
2025
Q2 | $3.08M | Buy |
41,319
+17,944
| +77% | +$1.41M | 0.01% | 668 |
|
|
2025
Q1 | $2.06M | Sell |
23,375
-170
| -0.7% | -$16.1K | 0.01% | 725 |
|
|
2024
Q4 | $2.15M | Sell |
23,545
-35
| -0.1% | -$3.59K | 0.01% | 742 |
|
|
2024
Q3 | $2.64M | Sell |
23,580
-19,028
| -45% | -$1.9M | 0.01% | 688 |
|
|
2024
Q2 | $4.17M | Buy |
42,608
+20,183
| +90% | +$2M | 0.01% | 580 |
|
|
2024
Q1 | $2.25M | Buy |
+22,425
| New | +$1.97M | 0.01% | 736 |
|
|
2023
Q2 | – | Sell |
-12,374
| Closed | -$1.04M | – | 1107 |
|
|
2023
Q1 | $1.04M | Buy |
+12,374
| New | +$1.06M | ﹤0.01% | 858 |
|
|
2021
Q4 | – | Sell |
-4,534
| Closed | -$456K | – | 1207 |
|
|
2021
Q3 | $456K | Sell |
4,534
-100,966
| -96% | -$11.1M | ﹤0.01% | 1074 |
|
|
2021
Q2 | $12.3M | Sell |
105,500
-3,200
| -3% | -$384K | 0.03% | 469 |
|
|
2021
Q1 | $12M | Sell |
108,700
-44,600
| -29% | -$4.84M | 0.04% | 473 |
|
|
2020
Q4 | $15.4M | Buy |
153,300
+26,400
| +21% | +$2.45M | 0.05% | 392 |
|
|
2020
Q3 | $9.91M | Sell |
126,900
-76,700
| -38% | -$5.78M | 0.04% | 461 |
|
|
2020
Q2 | $14.2M | Buy |
203,600
+41,806
| +26% | +$2.63M | 0.06% | 352 |
|
|
2020
Q1 | $7.54M | Buy |
161,794
+122,200
| +309% | +$7.85M | 0.04% | 427 |
|
|
2019
Q4 | $3.14M | Sell |
39,594
-141,600
| -78% | -$10.9M | 0.01% | 733 |
|
|
2019
Q3 | $13.4M | Sell |
181,194
-116,806
| -39% | -$8.38M | 0.05% | 390 |
|
|
2019
Q2 | $23.2M | Buy |
298,000
+54,914
| +23% | +$4.17M | 0.09% | 270 |
|
|
2019
Q1 | $18.4M | Buy |
243,086
+180,482
| +288% | +$14.3M | 0.07% | 319 |
|
|
2018
Q4 | $4.58M | Buy |
62,604
+46,900
| +299% | +$3.74M | 0.02% | 632 |
|
|
2018
Q3 | $1.5M | Sell |
15,704
-3,700
| -19% | -$367K | 0.01% | 944 |
|
|
2018
Q2 | $1.94M | Buy |
19,404
+3,704
| +24% | +$391K | 0.01% | 862 |
|
|
2018
Q1 | $1.66M | Sell |
15,700
-2,500
| -14% | -$253K | 0.01% | 887 |
|
|
2017
Q4 | $1.69M | Buy |
18,200
+4,000
| +28% | +$363K | 0.01% | 892 |
|
|
2017
Q3 | $1.28M | Hold |
14,200
| – | – | 0.01% | 906 |
|
|
2017
Q2 | $1.19M | Buy |
14,200
+200
| +1% | +$16.1K | 0.01% | 893 |
|
|
2017
Q1 | $1.13M | Buy |
14,000
+500
| +4% | +$39.3K | 0.01% | 905 |
|
|
2016
Q4 | $1.01M | Sell |
13,500
-181,100
| -93% | -$13.1M | ﹤0.01% | 904 |
|
|
2016
Q3 | $13.2M | Buy |
194,600
+161,700
| +491% | +$10.9M | 0.06% | 331 |
|
|
2016
Q2 | $2.23M | Sell |
32,900
-5,400
| -14% | -$397K | 0.01% | 724 |
|
|
2016
Q1 | $2.77M | Buy |
38,300
+14,500
| +61% | +$950K | 0.01% | 693 |
|
|
2015
Q4 | $1.61M | Sell |
23,800
-900
| -4% | -$63K | 0.01% | 819 |
|
|
2015
Q3 | $1.6M | Hold |
24,700
| – | – | 0.01% | 816 |
|
|
2015
Q2 | $2.02M | Sell |
24,700
-104,380
| -81% | -$8.05M | 0.01% | 787 |
|
|
2015
Q1 | $8.94M | Sell |
129,080
-528,920
| -80% | -$38.2M | 0.04% | 425 |
|
|
2014
Q4 | $49.9M | Buy |
658,000
+351,500
| +115% | +$27.8M | 0.2% | 144 |
|
|
2014
Q3 | $24.8M | Buy |
306,500
+182,600
| +147% | +$15.2M | 0.11% | 224 |
|
|
2014
Q2 | $10.8M | Sell |
123,900
-17,400
| -12% | -$1.51M | 0.05% | 386 |
|
|
2014
Q1 | $12.2M | Sell |
141,300
-889,133
| -86% | -$72.9M | 0.05% | 340 |
|
|
2013
Q4 | $83.2M | Sell |
1,030,433
-38,400
| -4% | -$2.98M | 0.37% | 62 |
|
|
2013
Q3 | $83.3M | Sell |
1,068,833
-65,680
| -6% | -$5.06M | 0.41% | 57 |
|
|
2013
Q2 | $79.4M | Buy |
+1,134,513
| New | +$79.1M | 0.42% | 55 |
|
Other funds holding EMN
Axa's EMN Position: Q3 2025 in Review
Axa sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 41,319 shares — an estimated $3.08M sold.
Axa first reported a position in EMN in Q2 2013 and held it in 41 quarters. The position peaked at $83.3M in Q3 2013. 663 funds tracked by Wall St. Rank hold EMN as of Q3 2025.
- Axa reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
- Axa sold 41,319 Eastman Chemical shares in Q3 2025, an estimated $3.08M.
- Axa first reported a position in Eastman Chemical in Q2 2013 and held it in 41 quarters.
- Axa's Eastman Chemical position peaked at $83.3M in Q3 2013.
- 663 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.